2011-19: Ketamine Treatment: Promise for the Future and How Nurses Impact Care
2011-19: Paula S. Bolton, MS, CNP, ANP-BC; Courtney Miller, RN
Treatment resistant depression and acute suicidality may be effectively treated with ketamine. Nurses play a key role in the development of treatment sites to assess suitability, develop treatment plans, monitor treatment and treatment outcomes, and manage follow up care for patients receiving this treatment.
Presenters: Paula S. Bolton, MS, CNP, ANP-BC; Courtney Miller, RN
Disclosures: The presenters and planners have no conflict of interest or commercial support to disclose. Off-label use of medications will be discussed during this presentation.
Session Length: 45 minutes
Target Audience: RN, APRN
Upon completion of this presentation, the participant will be able to:
- Explore the use of ketamine, ketamine derivatives, criteria for treatment, and the interdisciplinary nature of the treatment team, including the role of the PMH nurse in aiding recovery.
Keywords: IV Ketamine Infusion, Intranasal Ketamine Administration, Treatment Resistant Depression
Nursing Continuing Professional Development:
0.75 pharmacology contact hours. * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.
The American Psychiatric Nurses Association is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
APNA 33rd Annual Conference
New Orleans, Louisiana
The contact hours for this session expire: November 30, 2021